Qiming Jane Wang (Jane Q Wang, Bing Wang)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Locally Advanced

Cancer Stem Cells

Radical Prostatectomy

Top Venues

Nature communications

Translational stroke research

Molecular neurobiology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Yapeng Chao, Yuzhou Chen, Wenxiao Zheng, Kathryn Demanelis, Yu Liu, Jaclyn A Connelly, Hong Wang, Song Li, Qiming Jane Wang
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer. Oncogene 43 (11) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Zhangyi Luo, Yixian Huang, Neelu Batra, Yuang Chen, Haozhe Huang, Yifei Wang, Ziqian Zhang, Shichen Li, Chien-Yu Chen, Zehua Wang, Jingjing Sun, Qiming Jane Wang, Da Yang, Binfeng Lu, James F Conway, Lu-Yuan Li, Ai-Ming Yu, Song Li
Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy. Nature communications 15 (1) (2024)
Xuejing Zhang, Jaclyn Connelly, Yapeng Chao, Qiming Jane Wang
Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases. Biomolecules 11 (3) (2021)
Yinan Jiang, Yichen Guo, Jinjin Hao, Rachael Guenter, Justin D Lathia, Adam W Beck, Reagan Hattaway, Douglas Hurst, Qiming Jane Wang, Yehe Liu, Qi Cao, Helen Krontiras, Herbert Chen, Roy L Silverstein, Bin Ren
Development of an arteriolar niche and self-renewal of breast cancer stem cells by lysophosphatidic acid/protein kinase D signaling. Communications biology 4 (1) (2021)
Xuejing Zhang, Jaclyn Connelly, Edwin S Levitan, Dandan Sun, Qiming Jane Wang
Calcium/Calmodulin-Dependent Protein Kinase II in Cerebrovascular Diseases. Translational stroke research 12 (4) (2021)
Jing Ye, Sabyasachi Das, Adhiraj Roy, Wenzhong Wei, Huachen Huang, Joshua Michael Lorenz-Guertin, Qian Xu, Tija C Jacob, Qiming Jane Wang, Dandan Sun, Qiming Jane Wang
Ischemic Injury-Induced CaMKIIδ and CaMKIIγ Confer Neuroprotection Through the NF-κB Signaling Pathway. Molecular neurobiology 56 (3) (2018)